IL17A and Miyoshi myopathy: In a retrospective study, serum IL-6 level > 3 pg/mL, serum IL-17A level > 4 pg/mL, and treatment regimens were found to be independent prognostic factors for PFS and OS according to multivariate analyses of selected serum cytokine levels in patients with newly diagnosed MM.